You are in the accessibility menu

Statistics

Total Visits

Views
Cost-effectiveness of imatinib versus interferon-alpha in the treatment of patients newly diagnosed with chronic myeloid leukemia, under the Brazilian public healthcare system perspective. 93

Total Visits per Month

February 2025 March 2025 April 2025 May 2025 June 2025 July 2025 August 2025
Cost-effectiveness of imatinib versus interferon-alpha in the treatment of patients newly diagnosed with chronic myeloid leukemia, under the Brazilian public healthcare system perspective. 9 3 5 8 1 3 6

File Downloads

Views

Top Country Views

Views
Germany 23
United States 18
Brazil 12
China 7
Russia 6
Ukraine 4
United Kingdom 3
Iraq 2
Venezuela 2
Costa Rica 1

Top City Views

Views
Ashburn 6
Jacksonville 5
Nanjing 3
Caracas 2
Ankara 1
Aptos 1
Baghdad 1
Belo Horizonte 1
Blue Bell 1
Cachoeirinha 1